Methods and compositions for the repair and/or regeneration of damaged myocardium
Methods, compositions, and kits for repairing damaged myocardium and/or myocardial cells including the administration cytokines are disclosed and claimed. Methods and compositions for the development of large arteries and vessels are also disclosed and claimed. The present application also discloses and claims methods and media for the growth, expansion, and activation of human cardiac stem cells.
1. A method for repairing structure and function of damaged myocardium in a patient in need thereof comprising: extracting cardiac stem cells from the patient; culturing and expanding said cardiac stem cells, said cardiac stem cells being c-kit positive and characterized by their ability to differentiate into myocytes, endothelial cells, and smooth muscle cells; and administering a dose of said extracted and expanded cardiac stem cells to an area of damaged myocardium in the patient effective to ameliorate the structure and function of the damaged myocardium.
2. The method of claim 1 , wherein extracting cardiac stem cells from the patient comprises harvesting myocardial tissue from the patient and isolating the cardiac stem cells from said myocardial tissue.
3. The method of claim 2 , wherein the cardiac stem cells are isolated using a labeled antibody to c-kit and a sorting mechanism.
4. The method of claim 1 , wherein the extracted and expanded cardiac stem cells are administered to a border region of the damaged myocardium.
5. The method of claim 4 , wherein the extracted and expanded cardiac stem cells are administered intraarterially.
6. The method of claim 1 , wherein the extracted and expanded cardiac stem cells are administered via a catheter system.
7. The method of claim 1 , wherein the extracted and expanded cardiac stem cells are administered by injection.
8. The method of claim 1 , wherein the extracted and expanded cardiac stem cells are administered intraarterially.
9. The method of claim 1 , wherein the damaged myocardium is an infarction.
10. The method of claim 1 , further comprising administering one or more cytokines to the patient's heart.
11. The method of claim 10 , wherein the one or more cytokines are selected from the group consisting of hepatocyte growth factor, insulin-like growth factor-1, and combinations thereof.
12. The method of claim 10 , wherein the one or more cytokines are administered simultaneously with the extracted and expanded cardiac stem cells.
13. The method of claim 1 , wherein the extracted and expanded cardiac stem cells are activated by exposure to one or more cytokines prior to administration.
14. The method of claim 13 , wherein the one or more cytokines are selected from the group consisting of hepatocyte growth factor, insulin-like growth factor-1, and combinations thereof.
15. The method of claim 14 , wherein the hepatocyte growth factor is present in an amount between 0-400 ng/ml.
16. The method of claim 14 , wherein the insulin-like growth factor-1 is present in an amount between 0-500 ng/ml.
17. The method of claim 13 , wherein at least some of the differentiated cardiac stem cells form myocardial tissue and coronary vessels.
18. The method of claim 17 , wherein the coronary vessels comprise one or more selected from the group consisting of coronary arteries, coronary arterioles, and coronary capillaries.
19. The method of claim 17 , wherein at least one of the coronary vessels provides a bypass for an occluded or obstructed artery or vessel.
20. The method of claim 1 , wherein the cardiac stem cells express c-Met and/or IGF-1 receptor.
21. The method of claim 1 , wherein the cardiac stem cells are 5-7 μm in diameter.
22. A biotechnological process of repairing structure and function of damaged myocardium in a patient in need thereof comprising: extracting cardiac stem cells from the patient; culturing and expanding said cardiac stem cells, said cardiac stem cells being c-kit positive and characterized by their ability to differentiate into myocytes, endothelial cells, and smooth muscle cells; activating the extracted and expanded cardiac stem cells; and administering a dose of said activated cardiac stem cells to an area of damaged myocardium in the patient effective to ameliorate the structure and function of the damaged myocardium.
23. A biotechnological process for forming a biological coronary bypass in a patient in need thereof comprising: extracting cardiac stem cells from the patient; culturing and expanding said cardiac stem cells; activating the extracted and expanded cardiac stem cells; and administering an effective dose of said activated cardiac stem cells to the location in which a coronary vessel is occluded in the patient, said activated cardiac stem cells forming conductive coronary vessels after their administration, thereby forming a biological coronary bypass.